Mantle cell lymphoma. MCL is a rare and aggressive type of non-Hodgkin lymphoma. It is considered incurable with current treatments and often comes back. Many people are diagnosed ...

Artificial intelligence has huge potential to improve health and care, but its use must be safe, effective and fair. In this ...

Around 6,600 people in England with a serious heart condition will be able to access a new treatment following simultaneous MHRA authorisation and NICE approval today. Aficamten, also known as Myqorzo ...

With only 1 in 5 donated lungs currently considered suitable for use, the introduction of the XVIVO Perfusion System for a 4-year period while evidence is generated, could benefit hundreds of NHS ...

NICE is unable to make a recommendation on lutetium-177 vipivotide tetraxetan (Pluvicto) for treating prostate-specific membrane antigen (PSMA)-positive hormone-relapsed metastatic prostate cancer in ...